ReviewLife (Basel, Switzerland)2025

Risk Factors Associated with the Development of Immune-Checkpoint Inhibitor Diabetes Mellitus: An Integrative Review.

Vivian Crowder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.